TAKE LIMITED, together with its subsidiaries, provides domain-intensive services in life sciences and supply chain industries in India. The company offers intelligent platforms across life sciences, clinical research, biotechnology, and preventive healthcare. It also provides collaboration platform services, including subscription based software, implementation and configuration, maintenance and support, and other pr...
TAKE LIMITED is currently fairly valued (P/E: 26.64). The stock has pulled back today.